top of page
Biotech Funding


Fall 2025 Capital Deployment: A Defining Moment for Longevity Investment
More than $5B in longevity and biotech capital was raised globally between July and November 2025. From reprogramming therapeutics to preventive clinics, the sector is entering a pivotal consolidation phase. Here’s what the new funding wave means for longevity’s future.

Longevity Investors
Nov 213 min read
bottom of page